PARAINFLUENZAE VIRUS INFECTION

Clinical trials for PARAINFLUENZAE VIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new PARAINFLUENZAE VIRUS INFECTION trials appear

Sign up with your email to follow new studies for PARAINFLUENZAE VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First-of-its-Kind triple virus vaccine tested in seniors

⭐️ VACCINE ⭐️ Ongoing

This early-stage study is testing a new vaccine designed to protect against three common respiratory viruses: RSV, human metapneumovirus, and parainfluenza type 3. Researchers are giving different dose combinations to 390 adults aged 60 and older to check if the vaccine is safe a…

Matched conditions: PARAINFLUENZAE VIRUS INFECTION

Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 23, 2026 15:19 UTC

PARAINFLUENZAE VIRUS INFECTION

Get alerted when new PARAINFLUENZAE VIRUS INFECTION trials appear

First-of-its-Kind triple virus vaccine tested in seniors